Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures

Clinical Endocrinology

Volumn 47, Issue 6, 1997, Pages 667-677

  Munoz Hoyos A ^a   Molina Carballo, A ^a   Rodriguez Cabezas T ^a   Uberos Fernandez J ^a   Ruiz Cosano, C ^a   Acuna Castroviejo D ^b,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLE DERIVATIVE; KYNURENINE; MELATONIN; TRYPTOPHAN;

AMINO ACID METABOLISM; ARTICLE; BLOOD LEVEL; CHILD; EPILEPSY; EPILEPTOGENESIS; FEBRILE CONVULSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031439448     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2991136.x     Document Type: Article

References (57)

1. Acuña-Castroviejo, D., Lowenstein, P.R., Rosentein, R.E. & Cardinali, D.P. (1986a) Diurnal variations of benzodiazepine binding in rat cerebral cortex: disruption in pinealectomy. Journal of Pineal Research, 3, 101-109.
2. Acuña-Castroviejo, D., Castillo, J.L., Fernández, B., Gomar, M.D. & Del Aguila, C.M. (1992) Modulation by pineal gland of ouabain high-affinity binding sites in rate cerebral cortex. American Journal of Physiology, 262, R698-R706.
3. Acuña-Castroviejo, D., Escames, G., Macias, M., Muñoz-Hoyos, A., Molina-Carballo, A., Montes, R. & Vives, F. (1995) Cell protective role of melatonin in brain. Journal of Pineal Research, 19, 57-63.
4. Acuña-Castroviejo, D., Rosenstein, R.E., Romeo, H.E. & Cardinali, D.P. (1986b) Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administrations to rats. Neuroendocrinology, 43, 24-31.
5. Alberati-Giani, D., Ricciardi-Castagnoli, P., Köhler, C. & Cesura, A.M. (1996) Regulation of the kynurenic metabolic pathway by interferon-in murine cloned macrophages and microglial cells. Journal of Neurochemistry, 66, 996-1004.
6. Albertson, T.E., Peterson, S.L., Stark, L.G. & Lakin, M.L. (1981) The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology, 20, 61-66.
7. Anderson, W.W., Swartzwelder, H.S. & Wilson, W.A. (1987) The NMDA receptor antagonist 2-amino-5-phosphonovalerate blocks stimulus train-induced epileptogenesis but not epileptiform bursting in the rat hippocampal slice. Journal of Neurophysiology, 57, 1-21.
8. Anton-Tay, F. (1974) Melatonin: effects on brain function. Advances in Biochemical Psychoparmacology, 11, 315-324.
9. Auricchio, S., Quagliarello, E. & Rubino, A. (1960) Interrelation of tryptophan and nicotinic acid in man during the first month of life. Nature, 186, 639-640.
10. Beninger, R.J., Jhamandas, K., Boegman, R.J. & El-Defawy, S.R. (1986) Kynurenic acid-induced protection on neurochemical and behavioural deficits produced by quinolinic acid injections into the nucleus basalis of rats. Neuroscience Letters, 68, 317-321.
11. Bleck, T.P. & Klawans, H.L. (1992) Convulsive disorders: mechanisms of epilepsy and anticonvulsant action. In Textbook of Clinical Neuropharmacology and Therapeutics (ed. H.L. Klawans), pp. 23-30. Raven Press, New York.
12. Cardinali, D.P. (1981) Melatonin: a mammalian pineal hormone. Endocrine Reviews, 2, 327-346.
13. Castillo-Romero, J.L., Vives-Montero, F. & Acuña-Castroviejo, D. (1993) Pineal modulation of the rat caudate-putamen spontaneous neuronal activity: roles of melatonin and vasotocin. Journal of Pineal Research, 15, 147-152.
14. Champney, T.H. & Peterson, S.L. (1993) Circadian, seasonal, pineal and melatonin influences on epilepsy. In Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications (eds H.S. Yu & R.J. Reiter), pp. 477-494. CRC Press, London.
15. Champney, T.H., Sánchez-Forte, M., Muñoz-Hoyos, A., Molina-Carballo, A., Moreno-Madrid, F. & Acuña-Castroviejo, D. (1995) Anticonvulsant effects of melatonin in humans: two case studies. Society for Neuroscience, 25th Annual Meeting (Abstr.), p. 164. San Diego, USA.
16. Commission on Classification and Terminology (1989) The International League Against Epilepsy: proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 30, 389-399.
17. Coppini, D., Benassi, C.A. & Montorsi, M. (1959) Quantitative determination of tryptophan metabolites (via kynurenina) in biological fluids. Clinical Chemistry, 5, 391-401.
18. Escames, G., Arauzo, M., Acuña-Castroviejo, D. & Vives, F. (1996) Melatonin-dopamine interaction in the striatal protection area of sensory-motor cortex in the rat. NeuroReport, 7, 597-600.
19. 2+ epileptiform activity in human temporal slices. Experimental Brain Research, 107, 321-325.
20. Fernández, B., Malde, J.L., Montero, D. & Acuña, D. (1990) Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. Journal of Steroid Biochemistry, 35, 257-262.
21. Foster, A.C., Vezzani, A., French, E.D. & Schwarcz, R. (1984) Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neuroscience Letters, 48, 273-278.
22. Freer, D.E., Statland, B.E. & Sher, G. (1979) Quantification of disatured phosphatidylcholine and phosphatidylglycerol in amniotic fluid by fluorescence diminution: methodology and clinical results. Clinical Chemistry, 25, 960-968.
23. Fukui, S., Schwarcz, R., Rapoport, S.I., Takada, Y. & Smith, Q.R. (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. Journal of Neurochemistry, 56, 2007-2017.
24. Gastaut, H. (1983) Classification of status epilepticus. In Status Epilepticus - Mechanism on Brain Damage and Treatment (eds A.V. Delgado, C.G. Wasterlain, D.M. Treiman & R.J. Porter), pp. 25-35. Raven Press, New York.
25. Gholson, R.K., Nishizuka, Y., Ichiyama, A., Kaway, H., Nakamura, S. & Hayaisi, O. (1962) Tryptophan metabolism in man. New Intermediates in catabolism of tryptophan in mammalian liver. Journal of Biological Chemistry, 237, 2043-2045.
26. 3H]flunitrazepam binding. NeuroReport, 4, 987-990.
27. 3H-flunitrazepam receptor binding in the rat cerebral cortex. Neuroendocrinology, 60, 252-260.
28. Heyes, M.P. (1993) Metabolism and neurophatologic significance of quinolinic acid and quinurenic acid. Biochemical Society Transactions, 21, 83-89.
29. Heyes, M.P., Saito, K., Devinsky, O. & Nadi, N.S. (1994) Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures. Epilepsia, 35, 251-257.
30. Lapin, I.P. (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricle in mice. Journal of Neural Transmission, 42, 37-43.
31. Lapin, I.P. (1980) Effects of kynurenine and quinolinic acid on the action of convulsants in mice. Pharmacology, Biochemistry and Behavior, 13, 17-20.
32. Lapin, I.P. (1981) Nicotinamide, inosine and hypoxantine, putative endogenous ligands of the benzodiazepine receptor, opposite to diazepan are much more effective against kynurenine-induced seizures than against pentylenetetrazol-induced seizures. Pharmcology, Biochemistry and Behavior, 14, 589-593.
33. Lapin, I.P. (1982) Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships. Neuropharmacology, 21, 1227-1233.
34. Meldrum, B. (1987) Neurotransmitter amino acid in epilepsy. Electroencephalography and Clinical Neurophysiology, 39, 191-199.
35. Meldrum, B., Millan, M., Patel, S. & de Sarro, G. (1988) Anti-epileptic effects of focal microinjection of excitatory amino acid antagonists. Journal of Neural Transmission, 72, 191-200.
36. Mody, I., Stanton, P.K. & Heinemann, U. (1988) Activation of N-methyl-D-aspartate receptors parallels changes in cellular and synaptic properties of dentate gyrus granule cells after kindling. Journal of Neurophysiology, 59, 1033-1054.
37. Molina, A., Muñoz, A., Rodríguez, T., Acuña, D. & Molina, J.A. (1991) Variations in the metabolism of methoxyindoles and relationships with kynurenine in normal children and patients with febrile and epileptic convulsions. Journal of Endocrinological Investigation, 14, 199.
38. Molina-Carballo, A., Acuña-Castroviejo, D., Rodríguez-Cabezas, T. & Muñoz Hoyos A. (1994a) Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentrations in children. Journal of Pineal Research, 16, 1-9.
39. Molina-Carballo, A., Muñoz-Hoyos, A., Rodríguez Cabezas, T. & Acuña-Castroviejo, D. (1994b) Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children. Psychiatry Research, 52, 273-283.
40. Narbona, E., Muñoz, A., Galdõ, G. & Nuñez, J. (1986) Trastornos de la excreción urinaria de metabolitos del triptófano en niños con asfixia intraparto y anomalías psiconeurológicas. Laboratorio, 81, 321-137.
41. Narbona, E., Rodríguez, T., Moreno, F. & Uberos, J. (1994) Metabolismo del triptófano. Su importancia en patología infantil. In Aspectos Morfofuncionales y Fisiopatológicos de la Glándula Pineal. Consideraciones de Interés Pediátrico (eds A. Muñoz, J.M. Fernández & D. Acuña-Castroviejo), pp. 115-140. Nuevas Creaciones Médicas, Madrid.
42. Perkins, M.N. & Stone, T.W. (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interactions with endogenous excitatant quinolinic acid. Brain Research, 247, 183-187.
43. Perkins, M.N. & Stone, T.W. (1983) Pharmacology and regional variations of quinolinic acid-evoked excitations in rat central nervous system. Journal of Pharmacology and Experimental Therapeutics, 226, 551-557.
44. Petito, C.K., Schaefer, J.A. & Plum, F. (1977) Ultrastructural characteristics of the brain and blood-brain barrier in experimental seizures. Brain Research, 127, 251-267.
45. Pozo, D., Reiter, R.J., Calvo, J.R. & Guerrero, J.M. (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sciences, 55, 455-460.
46. Reiter, R.J. (1981) The mammalian pineal gland: structure and function. American Journal of Anatomy, 162, 287-313.
47. Reiter, R.J. (1983) The melatonin rhythm: both a clock and a calendar. Experientia, 49, 654-664.
48. Reiter, R.J. & Morgan, W.M. (1972) Attempts to characterize the convulsive response of parathyroidectomized rats to pineal gland removal. Physiology and Behavior, 9, 203-208.
49. Reiter, R.J., Blask, D.E., Talbot, J.A. & Barnett, M.P. (1973) Nature and the time course of seizures associated with surgical removal of the pineal gland from parathyroidectomized rats. Experimental Neurology, 38, 386-397.
50. Reiter, R.J., Melchiorri, D., Sewerynek, E., Poeggeler, B., Barlow-Walden, L., Chuang, J.I., Ortiz, G.G., & Acuña-Castroviejo, D. (1995) A review of the evidence supporting melatonin's role as antioxidant. Journal of Pineal Research, 18, 1-11.
51. Reiter, R.J., Menéndez-Paláez, A., Poeggeler, B., Tan, D.X., Pablos, M.I. & Acuña-Castroviejo, D. (1994) The role of melatonin in the pathophysiology of oxygen radical damage. In Advances in Pineal Research vol. 8 (eds M. Moller & P. Pévet), pp. 403-412. John Libbey, London.
52. Reiter, R.J., Sorrentino, S. & Hoffman, R.A. (1972) Muscular spasms and death in thyroparathyroidectomized rats subjected to pinealcctomy. Life Sciences, 11, 123-133.
53. Rodríguez, T., Muñoz, A., Molina, A., Narbona, E. & Molina, J.A. (1990) Urinary excretion of kynurenine and melatonin metabolites of tryptophan in convulsive disorders in children. Pediatric Research, 28, 304.
54. Snyderman, S.E., Boyer, A., Phansalkar, S.V. & Holt, L.E. (1961) Essential aminoacids requirement of infants. American Journal of Disease in Childhood, 102, 163-167.
55. Stone, W.E. & Javid, M.J. (1983) Effects of anticonvulsants and other agents on seizures induced by intracerebral L-glutamate. Brain Research, 264, 165-167.
56. Sudgen, D. (1983) Psychopharmacological effects of melatonin in mouse and rat. Journal of Pharmacology and Experimental Therapeutics, 227, 587-591.
57. 2+ decrease assessed in the hippocampus by brain dialysis. Brain Research, 454, 289-297.